title: Activation of heteroliganded mouse muscle nicotinic receptors.
abstract: The activation of the mouse muscle-type nicotinic acetylcholine receptor was studied in the presence of carbachol, and in the simultaneous presence of carbachol and choline. The channel currents were recorded under steady-state conditions using cell-attached single-channel patch clamp, and during transient exposures to the agonists using a piezo-driven fast application system. The presence of choline resulted in inhibition of currents elicited by carbachol. The inhibitory effect of choline manifested as a reduction in the effective opening rate (increase in the mean intracluster closed time duration) in single-channel recordings. In the fast application experiments, the peak current amplitude was reduced and the current rise time increased when choline was co-applied with carbachol. The data were analysed according to a model in which receptor interactions with carbachol and choline resulted in three types of ligation: receptors occupied by two carbachol molecules, receptors occupied by two choline molecules, and receptors in which one agonist binding site was occupied by carbachol and the other by choline, i.e. heteroliganded receptors. All three agonist-bound receptor populations could open albeit with different efficacies. The affinity of the resting receptor to choline was estimated to be 1-2 mm, and heteroliganded receptors opened with an opening rate constant of approximately 3000 s(-1). The results of the analysis suggest that the presence of choline in the neuromuscular junction in vivo has little effect on the time course of synaptic currents. Nevertheless, the contribution of heteroliganded receptors should be taken into consideration when the receptor is exposed simultaneously to two or more agonists.
authors.affiliation: Department of Anesthesiology, Washington University, Campus Box 8054, 660 S. Euclid Ave, St Louis, MO 63110, USA. akk@morpheus.wustl.edu
authors.forename: Gustav
authors.initials: G
authors.lastname: Akk
authors.forename: Lorin S
authors.initials: LS
authors.lastname: Milescu
authors.forename: Manfred
authors.initials: M
authors.lastname: Heckmann
mesh_terms: D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002460:Cell Line; D002794:Choline / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008024:Ligands; D051379:Mice; D032342:Muscle Cells / Q000187:drug effects / Q000378:metabolism*; D009469:Neuromuscular Junction / Q000187:drug effects / Q000378:metabolism*; D018722:Nicotinic Agonists / Q000494:pharmacology; D011978:Receptors, Nicotinic / Q000378:metabolism*
chemical_list: D008024:Ligands; D018722:Nicotinic Agonists; D011978:Receptors, Nicotinic; D002217:Carbachol; D002794:Choline
references.citation: J Gen Physiol. 2002 Sep;120(3):369-93
references.pmid: 12198092
references.citation: J Pharmacol Exp Ther. 2002 Sep;302(3):1246-52
references.pmid: 12183686
references.citation: J Neurobiol. 2002 Dec;53(4):479-500
references.pmid: 12436414
references.citation: J Neurophysiol. 2003 Apr;89(4):1797-806
references.pmid: 12611953
references.citation: J Pharmacol Exp Ther. 2003 Jun;305(3):1132-41
references.pmid: 12626641
references.citation: J Physiol. 2003 Aug 15;551(Pt 1):155-68
references.pmid: 12824448
references.citation: Ann N Y Acad Sci. 2003 Sep;998:41-52
references.pmid: 14592862
references.citation: J Physiol. 2003 Dec 15;553(Pt 3):857-71
references.pmid: 14555718
references.citation: J Physiol. 1972 May;223(1):173-97
references.pmid: 5046143
references.citation: J Physiol. 1976 Sep;260(3):531-52
references.pmid: 10432
references.citation: Proc R Soc Lond B Biol Sci. 1977 Nov 14;199(1135):231-62
references.pmid: 22856
references.citation: J Physiol. 1978 Apr;277:153-76
references.pmid: 306437
references.citation: Nature. 1980 Jul 3;286(5768):71-3
references.pmid: 6248795
references.citation: Pflugers Arch. 1981 Aug;391(2):85-100
references.pmid: 6270629
references.citation: Biophys J. 1984 Aug;46(2):277-83
references.pmid: 6478036
references.citation: Proc R Soc Lond B Biol Sci. 1985 Sep 23;225(1240):329-55
references.pmid: 2414779
references.citation: J Physiol. 1985 Dec;369:501-57
references.pmid: 2419552
references.citation: Brain Res. 1986 Jun 18;376(1):199-203
references.pmid: 3719368
references.citation: J Mol Biol. 1990 Aug 5;214(3):613-7
references.pmid: 2388258
references.citation: Biophys J. 1991 Aug;60(2):424-32
references.pmid: 1717017
references.citation: Synapse. 1993 Jan;13(1):57-62
references.pmid: 7678947
references.citation: Biophys J. 1993 Feb;64(2):339-56
references.pmid: 7681332
references.citation: J Pharmacol Exp Ther. 1993 Jun;265(3):1474-91
references.pmid: 8510023
references.citation: Mol Pharmacol. 1996 May;49(5):938-47
references.pmid: 8622644
references.citation: J Physiol. 1996 Apr 1;492 ( Pt 1):107-14
references.pmid: 8730587
references.citation: Biophys J. 1996 Jun;70(6):2652-8
references.pmid: 8744302
references.citation: Biophys J. 1996 Jan;70(1):264-80
references.pmid: 8770203
references.citation: J Physiol. 1996 Jul 1;494 ( Pt 1):155-70
references.pmid: 8814613
references.citation: Hum Mol Genet. 1997 May;6(5):767-74
references.pmid: 9158151
references.citation: J Gen Physiol. 1997 Jun;109(6):757-66
references.pmid: 9222901
references.citation: Am J Clin Nutr. 1997 Sep;66(3):622-5
references.pmid: 9280183
references.citation: J Physiol. 1998 Jan 1;506 ( Pt 1):53-72
references.pmid: 9481672
references.citation: J Gen Physiol. 1998 Aug;112(2):181-97
references.pmid: 9689026
references.citation: Biophys J. 1998 Oct;75(4):1817-27
references.pmid: 9746523
references.citation: J Physiol. 1999 Apr 15;516 ( Pt 2):315-30
references.pmid: 10087333
references.citation: J Neurosci. 2005 Feb 23;25(8):1992-2001
references.pmid: 15728839
references.citation: Biophys J. 2005 Apr;88(4):2494-515
references.pmid: 15681642
references.citation: Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10466-71
references.pmid: 10468632
references.citation: J Neurosci. 1995 Jan;15(1 Pt 1):230-40
references.pmid: 7529826
references.citation: Eur J Pharmacol. 1994 Oct 13;264(1):27-32
references.pmid: 7530203
references.citation: Science. 1995 Apr 14;268(5208):307-10
references.pmid: 7716527
references.citation: Eur J Pharmacol. 1995 Aug 15;290(3):207-19
references.pmid: 7589215
references.citation: Mol Pharmacol. 1996 Jan;49(1):1-6
references.pmid: 8569694
references.citation: Br J Pharmacol. 1999 Dec;128(7):1467-76
references.pmid: 10602325
references.citation: Eur J Pharmacol. 2000 Mar 30;393(1-3):209-14
references.pmid: 10771015
references.citation: Behav Brain Res. 2000 Aug;113(1-2):199-206
references.pmid: 10942046
references.citation: J Physiol. 2000 Sep 15;527 Pt 3:405-17
references.pmid: 10990529
references.citation: J Neurochem. 2000 Dec;75(6):2492-500
references.pmid: 11080202
references.citation: J Physiol. 2002 Nov 1;544(Pt 3):695-705
references.pmid: 12411516